Procter & Gamble (NYSE:PG) Stock Rating Reaffirmed by DA Davidson

Procter & Gamble (NYSE:PGGet Free Report)‘s stock had its “neutral” rating reaffirmed by stock analysts at DA Davidson in a research note issued to investors on Tuesday, Benzinga reports. They presently have a $159.00 target price on the stock. DA Davidson’s target price indicates a potential downside of 7.75% from the company’s current price. DA Davidson also issued estimates for Procter & Gamble’s Q1 2025 earnings at $1.90 EPS, FY2025 earnings at $6.98 EPS and FY2026 earnings at $7.40 EPS.

PG has been the topic of a number of other research reports. Evercore ISI boosted their price objective on shares of Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research report on Monday, September 30th. Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. boosted their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Finally, Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Nine analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $176.21.

Check Out Our Latest Analysis on PG

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $172.36 on Tuesday. The company’s fifty day moving average price is $171.72 and its 200 day moving average price is $167.00. Procter & Gamble has a 12 month low of $142.50 and a 12 month high of $177.94. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The firm has a market capitalization of $406.78 billion, a P/E ratio of 28.16, a P/E/G ratio of 3.67 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble’s quarterly revenue was down .1% on a year-over-year basis. During the same period in the previous year, the business posted $1.37 earnings per share. As a group, sell-side analysts predict that Procter & Gamble will post 6.97 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 3,373 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock worth $65,140,718 over the last ninety days. 0.17% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently modified their holdings of the stock. Legal & General Group Plc boosted its stake in shares of Procter & Gamble by 0.6% in the 2nd quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after purchasing an additional 122,190 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Procter & Gamble by 8.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock worth $1,598,510,000 after purchasing an additional 733,440 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Procter & Gamble by 9.7% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 6,161,507 shares of the company’s stock worth $999,705,000 after purchasing an additional 545,601 shares in the last quarter. Janus Henderson Group PLC increased its stake in Procter & Gamble by 1.3% during the 1st quarter. Janus Henderson Group PLC now owns 6,008,938 shares of the company’s stock worth $974,914,000 after purchasing an additional 79,665 shares in the last quarter. Finally, Canada Pension Plan Investment Board grew its stake in shares of Procter & Gamble by 3.9% during the 2nd quarter. Canada Pension Plan Investment Board now owns 5,706,199 shares of the company’s stock worth $941,066,000 after acquiring an additional 216,300 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.